Contribution of Individual Cytochrome P450 Isozymes to the O-Demethylation of the Psychotropic β-Carboline Alkaloids Harmaline and Harmine
- 1 April 2003
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 305 (1) , 315-322
- https://doi.org/10.1124/jpet.102.047050
Abstract
The psychotropic β-carboline alkaloids, showing high affinity for 5-hydroxytryptamine, dopamine, benzodiazepine, and imidazoline receptors and the stimulation of locus coeruleus neurons, are formed endogenously from tryptophan-derived indolealkylamines through the Pictet-Spengler condensation with aldehydes in both plants and mammals. Cytochromes P450 1A1 (18.5), 1A2 (20), and 2D6 (100) catalyzed theO-demethylation of harmaline, and CYP1A1 (98.5), CYP1A2 (35), CYP2C9 (16), CYP2C19 (30), and CYP2D6 (115) catalyzed that of harmine (relative activities). The dehydrogenation/aromatization of harmaline to harmine was not carried out by aromatase (CYP19), CYP1A2, CYP2C9, CYP2D6, CYP3A4, pooled recombinant cytochromes P450, or human liver microsomes (HLMs). Kinetic parameters were calculated for theO-demethylations mediated by each isozyme and by pooled HLMs. Kcat (min−1) andKm (μM) values for harmaline were: CYP1A1, 10.8 and 11.8; CYP1A2, 12.3 and 13.3; CYP2C9, 5.3 and 175; CYP2C19, 10.3 and 160; and CYP2D6, 39.9 and 1.4. Values for harmine were: CYP1A1, 45.2 and 52.2; CYP1A2, 9.2 and 14.7; CYP2C9, 11.9 and 117; CYP2C19, 21.4 and 121; and CYP2D6, 29.7 and 7.4. Inhibition studies using monoclonal antibodies confirmed that CYP1A2 and CYP2D6 were the major isozymes contributing to both harmaline (20% and 50%, respectively) and harmine (20% and 30%) O-demethylations in pooled HLMs. The turnover numbers for CYP2D6 are among the highest ever reported for a CYP2D6 substrate. Finally,CYP2D6-transgenic mice were found to have increased harmaline and harmine O-demethylase activities as compared with wild-type mice. These findings suggest a role for polymorphic CYP2D6 in the pharmacology and toxicology of harmine and harmaline.Keywords
This publication has 44 references indexed in Scilit:
- Alkaloids, alcohol and Parkinson's diseaseParkinsonism & Related Disorders, 2002
- Genotoxic and recombinogenic activities of the two β-carboline alkaloids harman and harmine in Saccharomyces cerevisiaeMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2002
- The CYP2D6 Humanized Mouse: Effect of the Human CYP2D6 Transgene and HNF4 on the Disposition of Debrisoquine in the MouseMolecular Pharmacology, 2001
- N-Methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading testJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
- Genotoxic potential of β-carbolines: A reviewMutation Research/Reviews in Genetic Toxicology, 1995
- Hypothermic effect of harmala alkaloid in rats: Involvement of serotonergic mechanismPharmacology Biochemistry and Behavior, 1995
- Indole‐N‐Methylation of β‐Carbolines: The Brain's Bioactivation Route to Toxins in Parkinson's Disease?a,bAnnals of the New York Academy of Sciences, 1992
- β-Carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?Neuroscience Letters, 1985
- Occurrence of 6-hydroxy-1-methyl-1,2,3,4-tetrahydro-β-carboline in tissues and body fluids of ratBiochemical Pharmacology, 1983
- Species and Phenobarbitone-Induced Differences in the Kinetic Constants of Liver Microsomal HarmineO-DemethylationXenobiotica, 1976